Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTERPARFUMS INCIPAR · Entity 4092 | Director | January 23, 2026 | January 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTERPARFUMS INC
Report date January 23, 2026 · Filed January 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,063 |
Reported balance
After 2026-01-23 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2026-01-23 · Exercise / conversion · Acquired 1,500 · Balance 30,063 |
| Common StockSEC Table I · non-derivative | Direct | 28,563 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 28,563 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 0 |
Reported balance
After 2026-01-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-23 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 0 |
Reported balance
After 2026-01-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-01-23 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 0 |
Reported balance
After 2026-01-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-23 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 0 |
Reported balance
After 2026-01-23 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-01-23 · Exercise / conversion · Disposed 375 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-01-23 · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · Balance 300 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2021 Filed Nov 19, 2021 21:44 UTC | INTERPARFUMS INC IPAR · Entity 4092 | SaleCommon Stock | 131 | $93.43 | $12,239.95 |
DisclosureSEC source: 0001753926-21-000722 · ownership.xml · nonDerivative · entry 2 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,932 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:07 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006424 · ownership.xml · derivative · entry 21 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:07 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006424 · ownership.xml · derivative · entry 20 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:07 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006424 · ownership.xml · derivative · entry 19 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:07 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006424 · ownership.xml · derivative · entry 18 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001213900-20-045407 · ownership.xml · derivative · entry 6 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001213900-20-045407 · ownership.xml · derivative · entry 5 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001213900-20-045407 · ownership.xml · derivative · entry 4 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001213900-20-045407 · ownership.xml · derivative · entry 3 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2021-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 1,000 | $26.40 | $26,398.00 |
DisclosureSEC source: 0001213900-20-045407 · ownership.xml · nonDerivative · entry 2 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:09 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002544 · ownership.xml · derivative · entry 21 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:09 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002544 · ownership.xml · derivative · entry 20 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:09 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002544 · ownership.xml · derivative · entry 19 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:09 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002544 · ownership.xml · derivative · entry 18 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| December 09, 2019 Filed Dec 9, 2019 23:34 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $25.29 | $0.00 |
DisclosureSEC source: 0001213900-19-025694 · ownership.xml · derivative · entry 9 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2020-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 9, 2019 23:34 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $25.29 | $0.00 |
DisclosureSEC source: 0001213900-19-025694 · ownership.xml · derivative · entry 8 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2020-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 9, 2019 23:34 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $25.29 | $0.00 |
DisclosureSEC source: 0001213900-19-025694 · ownership.xml · derivative · entry 7 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2020-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 9, 2019 23:34 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $25.29 | $0.00 |
DisclosureSEC source: 0001213900-19-025694 · ownership.xml · derivative · entry 6 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2020-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 9, 2019 23:34 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 1,000 | $25.29 | $25,285.00 |
DisclosureSEC source: 0001213900-19-025694 · ownership.xml · nonDerivative · entry 1 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 22:03 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001842 · s115864_form4.xml · derivative · entry 21 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 22:03 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001842 · s115864_form4.xml · derivative · entry 20 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 22:03 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001842 · s115864_form4.xml · derivative · entry 19 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 22:03 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001842 · s115864_form4.xml · derivative · entry 18 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:24 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $32.12 | $0.00 |
DisclosureSEC source: 0001615774-18-014323 · s114684_form4.xml · derivative · entry 9 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2019-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:24 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $32.12 | $0.00 |
DisclosureSEC source: 0001615774-18-014323 · s114684_form4.xml · derivative · entry 8 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2019-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:24 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $32.12 | $0.00 |
DisclosureSEC source: 0001615774-18-014323 · s114684_form4.xml · derivative · entry 7 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2019-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:24 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $32.12 | $0.00 |
DisclosureSEC source: 0001615774-18-014323 · s114684_form4.xml · derivative · entry 6 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2019-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:24 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 1,000 | $32.12 | $32,120.00 |
DisclosureSEC source: 0001615774-18-014323 · s114684_form4.xml · nonDerivative · entry 1 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:13 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000820 · s108917_form-4.xml · derivative · entry 21 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:13 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000820 · s108917_form-4.xml · derivative · entry 20 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:13 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000820 · s108917_form-4.xml · derivative · entry 19 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:13 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000820 · s108917_form-4.xml · derivative · entry 18 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 15:26 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001615774-17-007013 · s108295_form-4.xml · derivative · entry 9 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 15:26 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001615774-17-007013 · s108295_form-4.xml · derivative · entry 8 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 15:26 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001615774-17-007013 · s108295_form-4.xml · derivative · entry 7 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 15:26 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001615774-17-007013 · s108295_form-4.xml · derivative · entry 6 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 15:26 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 1,000 | $21.76 | $21,755.00 |
DisclosureSEC source: 0001615774-17-007013 · s108295_form-4.xml · nonDerivative · entry 1 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:22 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000150 · doc4_4522.xml · derivative · entry 21 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:22 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000150 · doc4_4522.xml · derivative · entry 20 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:22 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000150 · doc4_4522.xml · derivative · entry 19 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:22 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000150 · doc4_4522.xml · derivative · entry 18 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:50 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 125 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001638599-16-001596 · doc4_4347.xml · derivative · entry 9 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125 shares Expires 2017-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:50 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 125 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001638599-16-001596 · doc4_4347.xml · derivative · entry 8 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125 shares Expires 2017-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:50 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 125 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001638599-16-001596 · doc4_4347.xml · derivative · entry 7 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125 shares Expires 2017-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:50 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 125 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001638599-16-001596 · doc4_4347.xml · derivative · entry 6 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125 shares Expires 2017-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:50 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 500 | $17.07 | $8,535.00 |
DisclosureSEC source: 0001638599-16-001596 · doc4_4347.xml · nonDerivative · entry 1 HEILBRONN FRANCOIS · CIK 0001211781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.